A new adventure begins!

I spoke with Mary Rollins today. She is the Research Nurse for Dale's clinical trial treatment. A tentative schedule has been set:

Sept. 17th!
7:30 AM............ NURSING ASSESSMENT
8:00 AM........... BLOOD/SPECIMEN COLLECTION
8:30 AM ...........EKG - RESTING
10:30 AM......... KARP, DANIEL M.D.
11:00 AM.......... CHEST, PA & LAT
Home to Pearland for a while
7:50 PM ............CT CHECKIN-DONT EAT 3 HR PRIOR
8:20 PM ............CT SCAN, CHEST


Time............... Appointments for 9/24/2009
8:00 AM.........BLOOD/SPECIMEN COLLECTION
8:45 AM ........PHARMACOLOGY SAMPLING
9:00 AM......... TRTMNT SCHEDULED,ORDERS NEEDED

Additional Treatment dates:
Oct. 15th
(Reevaluate) Nov. 5, Nov. 26
(Reevaluate) Dec. 17, and Jan. 7

Bloodwork needed on Oct. 1 and Oct. 8 can be drawn at a lab in Victoria

Dale is the 1st of 30 patients at MD Anderson that has been accepted into the Phase III Clinical Trial of Figitumumab. On Sept. 22nd, the computer will decide if he is getting this third medication or not! Pray he's randomized into the group getting Figitumumab!